BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 27677978)

  • 1. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
    Raja K; Parikh A; Webb H; Hothi D
    Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
    Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Christian MT; Webb NJ; Woolley RL; Afentou N; Mehta S; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
    Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
    Kainth D; Hari P; Sinha A; Pandey S; Bagga A
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):225-232. PubMed ID: 33478976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose versus conventional-dose prednisolone for nephrotic syndrome relapses: a randomized controlled non-inferiority trial.
    Sheikh S; Mishra K; Kumar M
    Pediatr Nephrol; 2021 Oct; 36(10):3143-3150. PubMed ID: 33861375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
    Ekka BK; Bagga A; Srivastava RN
    Pediatr Nephrol; 1997 Oct; 11(5):597-9. PubMed ID: 9323286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
    Hama T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Sako M; Saito-Oba M; Nozu K; Shima Y; Iijima K; Yoshikawa N;
    BMC Nephrol; 2018 Sep; 19(1):223. PubMed ID: 30200895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Yadav M; Sinha A; Khandelwal P; Hari P; Bagga A
    Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
    Webb NJA; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Deeks JJ; Wheatley K; Ives NJ;
    BMJ; 2019 May; 365():l1800. PubMed ID: 31335316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.
    Hiraoka M; Tsukahara H; Matsubara K; Tsurusawa M; Takeda N; Haruki S; Hayashi S; Ohta K; Momoi T; Ohshima Y; Suganuma N; Mayumi M;
    Am J Kidney Dis; 2003 Jun; 41(6):1155-62. PubMed ID: 12776266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
    Webb NJ; Frew E; Brettell EA; Milford DV; Bockenhauer D; Saleem MA; Christian M; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Booth J; Jones C; McKeever K; Cook W; Ives NJ;
    Trials; 2014 Apr; 15():147. PubMed ID: 24767719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
    Fu LS; Shien CY; Chi CS
    Nephron Clin Pract; 2004; 97(4):c137-41. PubMed ID: 15331936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
    Abeyagunawardena AS; Thalgahagoda RS; Dissanayake PV; Abeyagunawardena S; Illangasekera YA; Karunadasa UI; Trompeter RS
    Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of relapse among Nigerian children with steroid-sensitive nephrotic syndrome.
    Esezobor CI; Ladapo TA; Lesi FE
    Niger J Clin Pract; 2016; 19(2):254-8. PubMed ID: 26856291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of prednisolone alone and prednisolone plus fusidic acid in the treatment of children with steroid-responsive nephrotic syndrome.
    Cerkauskiene R; Kaltenis P
    Medicina (Kaunas); 2005; 41 Suppl 1():26-30. PubMed ID: 15901972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome.
    Basu B; Bhattacharyya S; Barua S; Naskar A; Roy B
    Clin Exp Nephrol; 2020 Jul; 24(7):622-629. PubMed ID: 32201918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
    Mishra OP; Abhinay A; Mishra RN; Prasad R; Pohl M
    J Trop Pediatr; 2013 Oct; 59(5):343-9. PubMed ID: 23619602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.
    Christian MT; Webb NJA; Mehta S; Woolley RL; Afentou N; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Prajapati H; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
    JAMA Pediatr; 2022 Mar; 176(3):236-243. PubMed ID: 34928294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
    Mishra OP; Thakur N; Mishra RN; Prasad R
    J Nephrol; 2012; 25(3):394-400. PubMed ID: 21928226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome.
    Srivastava RN; Vasudev AS; Bagga A; Sunderam KR
    Pediatr Nephrol; 1992 May; 6(3):247-50. PubMed ID: 1616833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.